Drug recall · May 5, 2021
Evrysdi recall
Why: Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot be used in combination with co-packed syringes.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total volume after constitution, Rx only, Distributed by: Genentech, Inc. NDC:50242-175-05
- Lots / codes
Lot #: B1001B05; B1001B08, Exp. Feb-2022
- Quantity
- 2,627 bottles
- Company
- Genentech Inc, South San Francisco, CA
- Distribution
- Distributed Nationwide in the USA.
- Initiated
- April 20, 2021 · Voluntary: Firm initiated
- Classified
- April 29, 2021
- Reported
- May 5, 2021
- Ended
- January 18, 2022
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.